H-Arg(Mbs)-OH

H-Arg(Mbs)-OH is a protected arginine derivative in which the α-amino group is blocked by an Mbs (2-methanesulfonylbenzyl) protecting group while the side-chain guanidinium functionality remains present and the molecule is provided as the free carboxylic acid. The structure therefore contains an Mbs-protected amino group and a carboxyl group (-COOH) alongside the arginine side chain bearing a strongly basic guanidinium group, with stereochemistry not specified in the product name. In peptide synthesis and related coupling workflows, the Mbs protection pattern supports controlled chemoselectivity by preventing side reactions at the α-amino position while preserving the arginine guanidinium for incorporation into peptide intermediates or for subsequent functionalization and analytical characterization.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP27247

CAS No:59052-83-4

Synonyms/Alias:(2R,8S)-2,8-diaminononanedioicacid;59014-27-6;AC1ODWO2;CTK8B9840;MolPort-023-331-665;(8S,2R)-Diaminononanedioicacid;ZINC1720128;8774AB;ANW-63280;AKOS015911655;AJ-30973;AK-87787;KB-206562;TC-152025;I14-37344

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C9H18N2O4
M.W/Mr.
344.39

H-Arg(Mbs)-OH is an L-arginine derivative bearing an N-protecting group on the guanidino nitrogen, where the side-chain guanidine is masked as an Mbs (mesitylenesulfonyl-type) protected functionality while the α-amino and α-carboxyl groups remain available as a free amino acid (amino acid hydrochloride-free form is not implied). The molecule retains the stereogenic center characteristic of L-arginine, enabling stereochemically defined peptide bond formation at the α-position. The protected guanidine reduces undesired side reactions during coupling and allows controlled deprotection to regenerate the strongly basic, hydrogen-bonding guanidinium motif. The presence of a carboxylic acid and an N-protected side chain makes H-Arg(Mbs)-OH a practical chiral amino acid intermediate for protected amino acid synthesis and downstream peptide construction where arginine side-chain integrity must be preserved.

1. Peptide Synthesis

H-Arg(Mbs)-OH is used in peptide synthesis workflows where an arginine residue with a protected guanidine is required to maintain chemoselectivity during N- and side-chain functional group manipulations. The α-amino and α-carboxyl groups support standard peptide coupling chemistry, while the Mbs-protected guanidine suppresses side reactions such as guanidinium participation in acylation or base-mediated rearrangements. Controlled deprotection can restore the native arginine side-chain for salt-bridge formation and specific hydrogen-bonding patterns in the resulting peptide. The resulting arginine-containing building block is suitable for preparing protected peptide intermediates and full-length peptides used in biochemical research and peptide-scaffold development.

2. Chemical Biology

H-Arg(Mbs)-OH is applied in chemical biology to generate arginine-functional peptide analogs and conjugation-ready intermediates that preserve the stereochemical and electrostatic character of the guanidinium group. The protected side-chain guanidine enables incorporation into peptide sequences without premature reactivity, while subsequent unmasking can expose a strongly basic handle for receptor-binding studies, protein interaction mapping, or affinity reagent design. The α-amino acid backbone supports incorporation into peptide tags used for mechanistic probes and sequence-defined biomolecule constructs. The ability to switch between protected and deprotected guanidine states supports iterative molecular design cycles common in amino acid derivatization and peptide-based chemical biology.

3. Bioconjugation Chemistry

H-Arg(Mbs)-OH serves as a protected amino acid precursor for bioconjugation strategies that require arginine-containing linkers or peptide motifs with controlled side-chain availability. The Mbs-protected guanidine can be carried through peptide assembly to avoid undesired conjugation during earlier steps, then converted to the free guanidinium for subsequent coupling to electrophiles or for noncovalent targeting interactions. The stereodefined L-arginine residue contributes predictable spatial placement of the cationic group within the conjugate architecture. Downstream use includes preparation of peptide-based affinity ligands, labeling scaffolds, and conjugation intermediates relevant to biomolecule modification and analytical reagent generation.

4. Pharmaceutical Manufacturing

H-Arg(Mbs)-OH is suitable for pharmaceutical manufacturing contexts that require robust, scalable peptide intermediate preparation with minimized side reactions from arginine guanidinium during process steps. The protected guanidine functionality supports manufacturing-compatible peptide coupling sequences by maintaining orthogonality between the α-functional groups and the side-chain during controlled synthetic operations. The ability to unmask the guanidine at a defined stage enables consistent formation of arginine-containing drug-like peptides or peptide fragments used as intermediates in larger synthetic routes. The compound's chiral amino acid structure and protection strategy align with industrial amino acid derivative handling where reproducibility of functional group timing is essential.

5. Process Chemistry Intermediate

H-Arg(Mbs)-OH is employed as a process chemistry intermediate for producing protected arginine building blocks and for designing synthetic routes that require stable guanidine masking throughout multi-step transformations. The carboxylic acid and α-amino functionality allow conversion into activated peptide-coupling derivatives while the Mbs-protected side chain remains inert to many conditions that would otherwise lead to guanidinium overreaction. The stereochemical integrity of the L-configuration supports downstream peptide assembly without racemization-driven impurity formation from chiral center disruption. The compound can be used to prepare standardized peptide coupling feedstocks and intermediate streams for fine chemical synthesis and specialty chemical production focused on amino acid derivative manufacturing.

Size
1 g;5 g;
InChI
1S/C9H18N2O4/c10-6(8(12)13)4-2-1-3-5-7(11)9(14)15/h6-7H,1-5,10-11H2,(H,12,13)(H,14,15)/t6-,7+
InChI Key
CZBYDJTWLGVCEV-KNVOCYPGSA-N
Canonical SMILES
C(CCC(C(=O)O)N)CCC(C(=O)O)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesEpitope Mapping ServicesPeptide Modification ServicesPeptide Analysis ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide CDMOCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers